Business
USRM Reaches Key Sales Milestone of Proprietary Adipocell™ Product
USRM Reaches Key Sales Milestone of Proprietary Adipocell™ Product.
About this update from U.s. Stem Cell, Inc.
[{"type":"text","content":"\n\n\n\nUSRM Reaches Key Sales Milestone of Proprietary Adipocell™ Product\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nUSRM Reaches Key Sales Milestone of Proprietary Adipocell™ Product\nCompany Poised to Be Industry Leader in Autologous Adipose Stem Cell Treatments\nPR Newswire\nSUNRISE, Fla., Jan. 15, 2018\n\n\n\nSUNRISE, Fla., Jan. 15, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced it has reached a key milestone of 10,000 kit sales of its proprietary Adipocell™ product, a direct result of its relationships with 287 clinics in the United States and 700+ physicians worldwide offering USRM's proprietary stem cell products and services.\n\n\n \n \n\n \nAdipocell™, which has been developed, marketed and distributed by USRM, enables physicians to separate potent stem cells from a patient's own (autologous) fat cells, which are harvested and reinserted in two-hours total, in a minimally invasive procedure. Stem cells are an important component of the body's ability to regenerate itself, and are rapidly becoming a mainstream trend in the field of regenerative medicine.\n\nUSRM is the premiere company in the United States that markets and manufactures an autologous adipose/stem cell separation kit. Autologous cells are not rejected by the body's immune system and, as a result, may be more compatible and effective in reversing damage and augmenting health.\n\nIn addition to trailblazing the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, USRM also has developed a training program for physicians who want to learn how to offer stem cell therapy to their patients.\n\nIn-person training involves a two-day, interactive, hands-on training course at USRM's Sunrise, Florida-based clinic, and includes integration of autologous cellular treatments, the extraction of lipoaspirate and bone marrow aspirate, as well as demonstrations on how to isolate ...